Evidence map›Paper›PMID 38758301›Full record

ArticleJournal of clinical immunology2024

Fatal Disseminated Hepatitis E in an Adult Patient with IKBKB GOF Mutation.

Leif G Hanitsch, Marion Muche, Helena Radbruch, Jörg Hofmann, Victor M Corman

Abstract readLetterCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Clinical Significance of IKBKB Mutations:Saudi medical journal · 2026
    Review
  3. Case Report: A novelFrontiers in immunology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leif G HanitschInstitute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Campus Virchow, Augustenburger Platz 1/ Südstraße 2, 13353, Berlin, Germany. leif-gunnar.hanitsch@charite.de.ORCID 0000-0002-8181-0093
Marion MucheDepartment of Gastroenterology, Infectious Diseases, and Rheumatology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-8088-6793
Helena RadbruchDepartment of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-6941-3397
Jörg HofmannLabor Berlin - Charité Vivantes GmbH, 13353, Berlin, Germany.ORCID 0000-0003-3966-515X
Victor M CormanLabor Berlin - Charité Vivantes GmbH, 13353, Berlin, Germany.ORCID 0000-0002-3605-0136

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis EHepatitis E virusI-kappa B KinaseFatal OutcomeFemaleHepatitis, ChronicHumansLiver CirrhosisMiddle AgedMutationRibavirinSevere Combined ImmunodeficiencyI-kappa B KinaseIKBKB protein, humanRibavirin

Identifiers

PMID38758301
PMCPMC11101494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.